CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 115 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,559,722 | $23,672,000 | 1.29% |
| Congress Park Capital LLC | 78,561 | $522,000 | 0.32% |
| Exane Asset Management | 63,820 | $424,403,000 | 0.28% |
| Perceptive Advisors | 2,577,043 | $17,137,000 | 0.25% |
| RTW INVESTMENTS, LP | 1,526,003 | $10,148,000 | 0.24% |
| Jackson Creek Investment Advisors LLC | 80,504 | $535,000 | 0.24% |
| HARBOURVEST PARTNERS LLC | 79,193 | $527,000 | 0.20% |
| TANG CAPITAL MANAGEMENT LLC | 112,880 | $751,000 | 0.14% |
| Virtus ETF Advisers LLC | 38,721 | $257,000 | 0.14% |
| GLOBEFLEX CAPITAL L P | 69,435 | $462,000 | 0.12% |